Therapeutic effects of the soluble epoxide hydrolase (sEH) inhibitor AUDA on atherosclerotic diseases

ISSN： 0031-7144

Source： Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol.70, Iss.1, 2015-01, pp. : 24-28

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel soluble epoxide hydrolase inhibitor protects mitochondrial function following stress

By Batchu Sri N. Lee Stephen B. Samokhvalov Victor Chaudhary Ketul R. El-Sikhry Haitham Weldon Steven M. Seubert John M.

Canadian Journal of Physiology and Pharmacology, Vol. 90, Iss. 6, 2012-06 ,pp. : 811-823

NRC Research Press

Access to resources Recommend Favorite

Soluble epoxide hydrolase inhibitors: a patent review

By Shen Hong C

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 7, 2010-07 ,pp. : 941-956

Informa Healthcare

Access to resources Recommend Favorite

Targeting Soluble Epoxide Hydrolase for Inflammation and Pain - An Overview of Pharmacology and the Inhibitors

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 11, Iss. 2, 2012-04 ,pp. : 143-158

Bentham Science Publishers

Access to resources Recommend Favorite

Soluble Epoxide Hydrolase as a Potential Key Factor for Human Prenatal Development

Cells Tissues Organs, Vol. 201, Iss. 4, 2016-04 ,pp. : 277-286

Karger

Access to resources Recommend Favorite

Soluble Epoxide Hydrolase Inhibitors and their Potential for Treatment of Multiple Pathologic Conditions

Current Medicinal Chemistry, Vol. 18, Iss. 4, 2011-02 ,pp. : 587-603

Bentham Science Publishers

Access to resources Recommend Favorite